Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan

Fumiaki Fujii, Masahiro Onozawa, Shota Yoshida, Naoki Miyashita, Daisuke Hidaka, Reiki Ogasawara, Mutsumi Takahata, Junichi Hashiguchi, Shota Yokoyama, Masahiro Chiba, Tomoyuki Saga, Taku Shimizu, Ikumi Kasahara, Akio Shigematsu, Katsuya Fujimoto, Satoshi Iyama, Tetsuyuki Igarashi, Shinichi Ito, Yoshihito Haseyama, Mizuha Kosugi-Kanaya, Takeshi Kondo, Takanori Teshima

Open source

DOI
10.1007/s12185-026-04193-3
Published
2026-03-19
Container
International Journal of Hematology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12185-026-04193-3,
  title = {Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan},
  author = {Fumiaki Fujii and Masahiro Onozawa and Shota Yoshida and Naoki Miyashita and Daisuke Hidaka and Reiki Ogasawara and Mutsumi Takahata and Junichi Hashiguchi and Shota Yokoyama and Masahiro Chiba and Tomoyuki Saga and Taku Shimizu and Ikumi Kasahara and Akio Shigematsu and Katsuya Fujimoto and Satoshi Iyama and Tetsuyuki Igarashi and Shinichi Ito and Yoshihito Haseyama and Mizuha Kosugi-Kanaya and Takeshi Kondo and Takanori Teshima},
  year = {2026},
  journal = {International Journal of Hematology},
  doi = {10.1007/s12185-026-04193-3},
  url = {https://doi.org/10.1007/s12185-026-04193-3}
}

RIS

TY  - JOUR
TI  - Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan
AU  - Fumiaki Fujii
AU  - Masahiro Onozawa
AU  - Shota Yoshida
AU  - Naoki Miyashita
AU  - Daisuke Hidaka
AU  - Reiki Ogasawara
AU  - Mutsumi Takahata
AU  - Junichi Hashiguchi
AU  - Shota Yokoyama
AU  - Masahiro Chiba
AU  - Tomoyuki Saga
AU  - Taku Shimizu
AU  - Ikumi Kasahara
AU  - Akio Shigematsu
AU  - Katsuya Fujimoto
AU  - Satoshi Iyama
AU  - Tetsuyuki Igarashi
AU  - Shinichi Ito
AU  - Yoshihito Haseyama
AU  - Mizuha Kosugi-Kanaya
AU  - Takeshi Kondo
AU  - Takanori Teshima
PY  - 2026
JO  - International Journal of Hematology
DO  - 10.1007/s12185-026-04193-3
UR  - https://doi.org/10.1007/s12185-026-04193-3
ER  - 

APA

Fujii, F., Onozawa, M., Yoshida, S., Miyashita, N., Hidaka, D., Ogasawara, R., Takahata, M., Hashiguchi, J., Yokoyama, S., Chiba, M., Saga, T., Shimizu, T., Kasahara, I., Shigematsu, A., Fujimoto, K., Iyama, S., Igarashi, T., Ito, S., Haseyama, Y., Kosugi-Kanaya, M., Kondo, T., & Teshima, T. (2026). Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan. International Journal of Hematology. https://doi.org/10.1007/s12185-026-04193-3

Source records